IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Dr. Roger Gomis (IRB Barcelona researcher, Inbiomotion Founder and CSO) and Dr. Joël Jean-Mairet (Inbiomotion Executive Chaiman)
Innovation
30 Sep 2021
IRB Barcelona spin-off Inbiomotion’s MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival
Innovation
27 Sep 2021
Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA, is launched with the support of Asabys
Salvador Aznar Beniath, IRB Barcelona
Scientific
22 Sep 2021
The circadian rhythm of the liver is regulated by muscle activity
Institutional
22 Sep 2021
The PERSIST-SEQ consortium kicks off to overcome resistance to cancer treatments
Community
21 Sep 2021
A new PI in town: An interview with Dr. Jordi Duran, new Group Leader at the IQS
Scientific
14 Sep 2021
Scientists reveal how the impact of chemotherapy on healthy cells affects the development of blood cells
Scientific
13 Sep 2021
Key element identified in stem cell division 
and embryo development
PIE
Scientific
9 Sep 2021
A new method to understand protein dynamics and the regulation of cellular processes
Researchers used whole-genome sequencing to characterize three molecular subtypes of lung cancer in people who had never smoked. Credit: National Cancer Institute
Scientific
7 Sep 2021
IRB Barcelona participates in a study that illuminates origins of lung cancer in never smokers

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog